⌘K

Login Start Free

Home/Filings/4/0001104659-21-104206

4//SEC Filing

SIEBERT JOHN M 4

Accession 0001104659-21-104206

CIK 0001356576other

View on SEC.gov Company Profile

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 4:32 PM ET

Size

6.7 KB

Accession

0001104659-21-104206

Insider Transaction Report

Form 4

Period: 2021-08-11

SUPERNUS PHARMACEUTICALS, INC.SUPN

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to Buy)
2021-08-11−15,000→ 0 total
Exercise: $12.98From: 2017-03-01Exp: 2026-03-01→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock
2021-08-11$12.98/sh+15,000$194,700→ 75,953 total

Documents

1 file

4
tm2124999-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1

filerCIK 0001190558

Filing Metadata

Form type: 4
Filed: Aug 11, 8:00 PM ET
Accepted: Aug 12, 4:32 PM ET
Size: 6.7 KB

View on SEC.gov